# Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome

> **NCT05298085** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 25 (actual)

## Conditions studied

- Prader-Willi Syndrome

## Interventions

- **DRUG:** Oxytocin nasal spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05298085
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-05
- **Primary completion:** 2023-04-11
- **Final completion:** 2023-04-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05298085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05298085, "Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05298085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*